# LORATADINE
> **ANDA211900** · Abbreviated New Drug Application (Generic) · Sponsor: AUROBINDO PHARMA · Approved 2023-03-24
## Drug
- **FDA Application Number:** ANDA211900
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** LORATADINE
- **Generic name:** LORATADINE
- **Active ingredients:** LORATADINE
- **Dosage form:** CAPSULE
- **Route:** ORAL
- **Marketing status:** Over-the-counter
- **Sponsor:** AUROBINDO PHARMA
- **Manufacturer:** Aurohealth LLC
- **First approval:** 2023-03-24
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211900)
---
*AI Analytics · CC0 1.0*